Alzheimer's Drug Discovery Foundation (ADDF)
The ADDF accelerates the discovery of drugs to prevent and treat Alzheimer's disease through research funding and portfolio management.
Detailed Introduction
The Alzheimer's Drug Discovery Foundation (ADDF) is dedicated to advancing the discovery of drugs to prevent and treat Alzheimer's disease. ADDF funds research programs focused on drug development, biomarkers, and prevention strategies. In 2024, ADDF catalyzed significant breakthroughs, including major investments in scalable blood tests and the cataloging of Alzheimer's biomarkers. The foundation also marked the 10th anniversary of the Goodes Prize and celebrated the FDA approval of Kisunla (Donanemab). ADDF's diverse portfolio is one of the largest worldwide, emphasizing lifestyle interventions and innovative diagnostics.
MoreResearch
UC Berkeley Psychology - Psychology Department at University of California, Berkeley
In 1921-2, in keeping with a growing trend across the nation, Berkeley's Department of Psychology was established as a separate unit, emerging from the Department of Philosophy. For nearly a century, the department has been a national and international leader in psychological research and the superior educational programs that we have provided to undergraduates and doctoral students.
JoVE
JoVE (Journal of Visualized Experiments) is an online peer-reviewed journal that publishes visual content for scientific and medical research, including psychology and neuroscience.
Psychomeasurement Systems - Software and Consulting Services
Psychomeasurement Systems offers a suite of psychometric analysis tools, including the open-source jMetrik and IRT Illustrator, providing comprehensive solutions for educational measurement and psychometrics. Explore our custom software, workshops, and consulting services.